Zhejiang Orient Gene Biotech Co Ltd Class A 688298
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥29.16
- Day Range
- ¥29.22–31.60
- 52-Week Range
- ¥24.40–45.44
- Bid/Ask
- ¥30.75 / ¥30.79
- Market Cap
- ¥6.21 Bil
- Volume/Avg
- 2.5 Mil / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.32
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Value
- Total Number of Employees
- 2,231
- Website
- http://www.orientgene.com
Comparables
Valuation
|
Metric
|
688298
|
688468
|
301060
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 18.73 | 29.68 |
Price/Book Value | 0.89 | 1.82 | 2.15 |
Price/Sales | 8.32 | 5.48 | 2.24 |
Price/Cash Flow | — | 12.83 | 48.96 |
Price/Earnings
688298
688468
301060
Financial Strength
|
Metric
|
688298
|
688468
|
301060
|
|---|---|---|---|
Quick Ratio | 3.58 | 4.71 | 2.66 |
Current Ratio | 4.05 | 5.48 | 3.27 |
Interest Coverage | −34.79 | 111.54 | −9.75 |
Quick Ratio
688298
688468
301060
Profitability
|
Metric
|
688298
|
688468
|
301060
|
|---|---|---|---|
Return on Assets (Normalized) | −7.14% | 7.46% | −4.28% |
Return on Equity (Normalized) | −8.68% | 9.59% | −7.03% |
Return on Invested Capital (Normalized) | −9.77% | 7.98% | −5.26% |
Return on Assets
688298
688468
301060
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Nlcsrftd | Lmfjjf | $195.6 Bil | |||
| Stryker Corp
SYK
| Rkjjysgns | Ppx | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Yfzvmfsm | Pcljbj | $122.7 Bil | |||
| Medtronic PLC
MDT
| Wqmtxmwv | Byzcv | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Wdmbqpxpk | Lwdgq | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Mntsq | Dhrjm | $30.7 Bil | |||
| DexCom Inc
DXCM
| Lxsnjwzh | Zvpqs | $27.0 Bil | |||
| Steris PLC
STE
| Nyfdghq | Jqvzjv | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Pnpljnrrg | Ctccg | $22.0 Bil | |||
| Insulet Corp
PODD
| Mjrbmfvt | Qjkbty | $16.3 Bil |
United States